5-Aminoimidazole-4-carboxamide-1--D-ribofuranoside (AICAr), a commonly used indirect activator of AMP-activated protein kinase (AMPK), inhibits phosphatidylcholine (PC) biosynthesis in freshly isolated hepatocytes. In all nucleated mammalian cells, PC is synthesized from choline via the Kennedy (CDP-choline) pathway. The purpose of our study was to provide direct evidence that AMPK regulates phospholipid biosynthesis and to elucidate the mechanism(s) by which AMPK inhibits hepatic PC synthesis. Incubations of hepatocytes with AICAr resulted in a dose-dependent activation of AMPK and inhibition of PC biosynthesis. Surprisingly, adenoviral delivery of constitutively active AMPK did not alter PC biosynthesis. In addition, expression of dominant negative mutants of AMPK was unable to block the AICAr-dependent inhibition of PC biosynthesis, indicating that AICAr was acting independently of AMPK activation. Determination of aqueous intermediates of the CDPcholine pathway indicated that choline kinase, the first enzyme in the pathway, was inhibited by AICAr administration. Flux through the CDP-choline pathway was directly correlated to the level of intracellular ATP concentrations. Therefore, it is possible that inhibition of PC biosynthesis is another process by which the cell can reduce ATP consumption in times of energetic stress. However, unlike cholesterol and triacylglycerol biosynthesis, PC production is not regulated by AMPK.
Phosphatidylcholine (PC)4 is quantitatively the most important phospholipid in mammalian membranes, is the primary phospholipid in bile and in plasma lipoproteins, and is a precursor for the synthesis of sphingomyelin and phosphatidylserine. In nucleated cells, PC biosynthesis occurs via the Kennedy (CDP-choline) pathway. Choline kinase (CK), the enzyme catalyzing the first committed step in this pathway, phosphorylates choline to form phosphocholine. Choline kinase is not considered an important site in regulating PC biosynthesis (1-3); however, deletion of the CK isoform results in muscular dystrophy in mice due to lack of PC in muscle (4). CTP:phosphocholine cytidylyltransferase (CT), which catalyzes the rate-limiting conversion of phosphocholine to CDPcholine (1-3), is the most extensively studied enzyme in the Kennedy pathway. CT is found in soluble cell and tissue extracts and bound to membranes. The active form of CT in cells is considered to be membrane-associated, whereas the soluble form is thought to be an inactive reservoir (5, 6). Movement of CT to and from the membrane is linked to cell requirements for PC and is tightly regulated (7-14). The lipid binding domain and the highly phosphorylated C terminus of CT are typically involved in regulating its activity. The last enzyme in the pathway, CDP-choline:1,2-diacylglycerol cholinephosphotransferase, is in excess in cells and thus does not determine the rate of PC biosynthesis. This reaction requires the availability of diacylglycerol, which is synthesized from fatty acids and glycerol.Hepatocytes are unique in that they can a...